AstraZeneca PLC

AZN June 2027 Options Begin Trading

24 أبريل 2025 10:32:42 بحسب NASDAQ US Markets

AZN June 2027 Options Begin Trading

24 أبريل 2025 10:29:50 بحسب NASDAQ Stocks

NetDania - New 12 months Low: ASTRAZENECA PLC

09 أبريل 2025 02:15:01 بحسب NetDania Notify

Relative Strength Alert For AstraZeneca

07 أبريل 2025 13:17:02 بحسب NASDAQ US Markets

Relative Strength Alert For AstraZeneca

07 أبريل 2025 13:09:15 بحسب NASDAQ Stocks

NetDania - New 12 months Low: ASTRAZENECA PLC

07 أبريل 2025 02:15:02 بحسب NetDania Notify

AstraZeneca And Daiichi Sankyo's Enhertu Approved In EU For Advanced Breast Cancer Treatment

04 أبريل 2025 01:42:00 بحسب NASDAQ US Markets

AZN Makes Bullish Cross Above Critical Moving Average

03 أبريل 2025 14:19:41 بحسب NASDAQ US Markets

Nasdaq 100 Movers: LULU, AZN

03 أبريل 2025 09:46:36 بحسب NASDAQ US Markets

Nasdaq 100 Movers: LULU, AZN

03 أبريل 2025 09:27:06 بحسب NASDAQ Stocks

AstraZeneca's Imfinzi Combo Approved In US For Muscle-Invasive Bladder Cancer Treatment

31 مارس 2025 01:48:35 بحسب NASDAQ US Markets

AZN : Study Confirms TAGRISSO As Essential Therapy For EGFR-Mutated Lung Cancer Across All Stages

25 مارس 2025 20:46:31 بحسب NASDAQ US Markets

Nasdaq 100 Movers: AZN, TSLA

24 مارس 2025 11:22:08 بحسب NASDAQ US Markets

AstraZeneca To Buy Belgium's Cell Therapy Firm EsoBiotec In Up To $1 Bln Deal

17 مارس 2025 02:30:11 بحسب NASDAQ US Markets

AZN May 2nd Options Begin Trading

13 مارس 2025 10:37:56 بحسب NASDAQ US Markets

AZN Makes Notable Cross Below Critical Moving Average

11 مارس 2025 10:58:07 بحسب NASDAQ US Markets

AZN : Imfinzi Improves Event-Free Survival In Early-Stage Gastric & GEJ Cancers In Phase III Trial

07 مارس 2025 01:51:13 بحسب NASDAQ US Markets

AZN: TEZSPIRE Reduces Nasal Polyp Severity And Surgery Need In CRSwNP Patients In Phase III Trial

01 مارس 2025 20:14:04 بحسب NASDAQ US Markets

AstraZeneca's Camizestrant Shows Positive Interim Results In SERENA-6 Phase 3 Trial

26 فبراير 2025 01:43:24 بحسب NASDAQ US Markets

FibroGen Announces Sale of China Subsidiary to AstraZeneca for Approximately $160 Million

20 فبراير 2025 06:51:49 بحسب NASDAQ Stocks